Professor receives prestigious 'Texty' award for textbook excellence
Patricia Tille recognized for contributions to "Bailey & Scott's Diagnostic Microbiology"
Patricia Tille, PhD. Photo/University of Cincinnati.
Patricia Tille, PhD, a faculty member at the University of Cincinnati's College of Allied Health Sciences, has been recognized with the Academic Authors Association (TAA) Textbook Excellence "Texty" Award for her outstanding contributions to clinical microbiology education.
Tille, who serves as the graduate program director in the Clinical Health and Information Sciences Department, has played a pivotal role in developing and updating the textbook "Bailey & Scott's Diagnostic Microbiology." This textbook is recognized as an impactful resource for clinical laboratory science education programs and practicing professionals worldwide.
Her commitment to maintaining the textbook's quality and relevance is commendable. Tille continuously collects and updates information to ensure the textbook reflects the latest developments in the field. This dedication has earned her the respect and admiration of her peers and the TAA Textbook Excellence Award.
In addition to her work on "Bailey & Scott's Diagnostic Microbiology," Tille has contributed chapters to other textbooks and remains actively involved in advancing the field of clinical microbiology. Her passion for education and research is evident in her work, inspiring students and colleagues alike.
Tille's recognition with the Textbook Excellence Award is a testament to her dedication and expertise in clinical microbiology. Her work has had a profound impact on the education of future laboratory professionals and underscores the importance of high-quality educational resources in advancing the field globally.
Featured image at top of "Bailey & Scott's Diagnostic Microbiology" textbook. Photo provided.
Related Stories
Professor receives prestigious 'Texty' award for textbook excellence
April 15, 2024
The University of Cincinnati's Patricia Tille has played a pivotal role and received a "Texty" award for developing and updating the textbook "Bailey & Scott's Diagnostic Microbiology."
A new treatment for rare muscular disease
April 16, 2021
Hani Kushlaf, MD, presented findings on a new treatment for Pompe disease, a rare neuromuscular disease, virtually at the American Academy of Neurology on April 17.
UC Blue Ash offers new program in high-demand medical specialty
February 18, 2021
The University of Cincinnati Blue Ash College is offering a new online program that prepares students to earn a certificate in a high-demand medical specialty in just one year.
A new co-driver in breast cancer
March 9, 2021
University of Cincinnati researchers have discovered that cooperation between two key genes drive cancer growth, spread and treatment resistance in one particularly aggressive type of breast cancer. The good news is, though, with this knowledge, they can continue to aim their targeted treatments at these genes, singularly and together, to stop breast cancer in its tracks.
Journal-News: UC studies art, pet robot therapy
February 7, 2022
The Journal-News featured the research of Dr. Soma Sengupta, Dr. Claudia Rebola and Dr. Meera Rastogi, who have developed an art therapy app and pet robot study to see how the interventions can affect the mental health of patients with vestibular schwannomas.
UC researcher receives patent for new breast cancer treatment
October 25, 2021
The University of Cincinnati's Dr. Xiaoting Zhang has been awarded a patent for a novel RNA nanoparticle treatment for breast cancer.
Breaking down cancer’s defenses
November 19, 2021
University of Cincinnati College of Pharmacy researchers have engineered a probiotic bacteria designed to break down cancer cell walls to allow therapies easier access to shrink tumors.
Innovative approaches to liver cancer care
October 11, 2021
The University of Cincinnati is opening a new clinical trial looking to see how the combination of immunotherapy and transplant can improve patient outcomes.
UC researcher receives prestigious award to further cancer research
December 7, 2021
The University of Cincinnati's Dr. Vladimir Bogdanov has been awarded a Catalyst Research Award to further investigate if a drug he and his team developed is effective in treating pancreatic cancer.
Personalized treatments for blood and bone cancer
September 30, 2021
University of Cincinnati researchers have joined a nationwide clinical trial exploring the effectiveness of personalized treatments for patients with acute myelogenous leukemia (AML), a cancer of the blood and bone marrow.